Global Mesalazine Market Outlook 2022

Publisher Name :
Date: 07-Jan-2022
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Purity ? 97 %

- Purity ? 98 %

- Purity ? 99 %

Segment by Application

- Tablets

- Capsules

- Pellet and Granule

- Suppository

- Enema

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- PharmaZell

- Syntese A/S

- Cambrex Corporation

- Divis Laboratories

- Chemi SpA

- Ipca Laboratories

- Hangzhou Brother

- Lianyungang Fengheng Biopharm

- Lasa Loboratory

- Corden Pharma Bergamo

- Erregierre SpA

- CTX Lifescience

- Ishita Active Pharma Ingredients

- YC Biotech (Jiangsu)

- Xinxiang Tianfeng Fine Chemical

Global Mesalazine Market Outlook 2022

Table of Contents
1 Mesalazine Market Overview
1.1 Product Overview and Scope of Mesalazine
1.2 Mesalazine Segment by Type
1.2.1 Global Mesalazine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Purity ? 97 %
1.2.3 Purity ? 98 %
1.2.4 Purity ? 99 %
1.3 Mesalazine Segment by Application
1.3.1 Global Mesalazine Sales Comparison by Application: (2021-2027)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Pellet and Granule
1.3.5 Suppository
1.3.6 Enema
1.3.7 Others
1.4 Global Mesalazine Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Revenue 2016-2027
1.4.2 Global Mesalazine Sales 2016-2027
1.4.3 Mesalazine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Mesalazine Market Competition by Manufacturers
2.1 Global Mesalazine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Mesalazine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Mesalazine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Mesalazine Manufacturing Sites, Area Served, Product Type
2.5 Mesalazine Market Competitive Situation and Trends
2.5.1 Mesalazine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Mesalazine Players Market Share by Revenue
2.5.3 Global Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mesalazine Retrospective Market Scenario by Region
3.1 Global Mesalazine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Mesalazine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Mesalazine Market Facts & Figures by Country
3.3.1 North America Mesalazine Sales by Country
3.3.2 North America Mesalazine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mesalazine Market Facts & Figures by Country
3.4.1 Europe Mesalazine Sales by Country
3.4.2 Europe Mesalazine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mesalazine Market Facts & Figures by Region
3.5.1 Asia Pacific Mesalazine Sales by Region
3.5.2 Asia Pacific Mesalazine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mesalazine Market Facts & Figures by Country
3.6.1 Latin America Mesalazine Sales by Country
3.6.2 Latin America Mesalazine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Mesalazine Market Facts & Figures by Country
3.7.1 Middle East and Africa Mesalazine Sales by Country
3.7.2 Middle East and Africa Mesalazine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Mesalazine Historic Market Analysis by Type
4.1 Global Mesalazine Sales Market Share by Type (2016-2021)
4.2 Global Mesalazine Revenue Market Share by Type (2016-2021)
4.3 Global Mesalazine Price by Type (2016-2021)
5 Global Mesalazine Historic Market Analysis by Application
5.1 Global Mesalazine Sales Market Share by Application (2016-2021)
5.2 Global Mesalazine Revenue Market Share by Application (2016-2021)
5.3 Global Mesalazine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 PharmaZell
6.1.1 PharmaZell Corporation Information
6.1.2 PharmaZell Description and Business Overview
6.1.3 PharmaZell Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 PharmaZell Mesalazine Product Portfolio
6.1.5 PharmaZell Recent Developments/Updates
6.2 Syntese A/S
6.2.1 Syntese A/S Corporation Information
6.2.2 Syntese A/S Description and Business Overview
6.2.3 Syntese A/S Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Syntese A/S Mesalazine Product Portfolio
6.2.5 Syntese A/S Recent Developments/Updates
6.3 Cambrex Corporation
6.3.1 Cambrex Corporation Corporation Information
6.3.2 Cambrex Corporation Description and Business Overview
6.3.3 Cambrex Corporation Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cambrex Corporation Mesalazine Product Portfolio
6.3.5 Cambrex Corporation Recent Developments/Updates
6.4 Divis Laboratories
6.4.1 Divis Laboratories Corporation Information
6.4.2 Divis Laboratories Description and Business Overview
6.4.3 Divis Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Divis Laboratories Mesalazine Product Portfolio
6.4.5 Divis Laboratories Recent Developments/Updates
6.5 Chemi SpA
6.5.1 Chemi SpA Corporation Information
6.5.2 Chemi SpA Description and Business Overview
6.5.3 Chemi SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Chemi SpA Mesalazine Product Portfolio
6.5.5 Chemi SpA Recent Developments/Updates
6.6 Ipca Laboratories
6.6.1 Ipca Laboratories Corporation Information
6.6.2 Ipca Laboratories Description and Business Overview
6.6.3 Ipca Laboratories Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Ipca Laboratories Mesalazine Product Portfolio
6.6.5 Ipca Laboratories Recent Developments/Updates
6.7 Hangzhou Brother
6.6.1 Hangzhou Brother Corporation Information
6.6.2 Hangzhou Brother Description and Business Overview
6.6.3 Hangzhou Brother Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Hangzhou Brother Mesalazine Product Portfolio
6.7.5 Hangzhou Brother Recent Developments/Updates
6.8 Lianyungang Fengheng Biopharm
6.8.1 Lianyungang Fengheng Biopharm Corporation Information
6.8.2 Lianyungang Fengheng Biopharm Description and Business Overview
6.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Lianyungang Fengheng Biopharm Mesalazine Product Portfolio
6.8.5 Lianyungang Fengheng Biopharm Recent Developments/Updates
6.9 Lasa Loboratory
6.9.1 Lasa Loboratory Corporation Information
6.9.2 Lasa Loboratory Description and Business Overview
6.9.3 Lasa Loboratory Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Lasa Loboratory Mesalazine Product Portfolio
6.9.5 Lasa Loboratory Recent Developments/Updates
6.10 Corden Pharma Bergamo
6.10.1 Corden Pharma Bergamo Corporation Information
6.10.2 Corden Pharma Bergamo Description and Business Overview
6.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Corden Pharma Bergamo Mesalazine Product Portfolio
6.10.5 Corden Pharma Bergamo Recent Developments/Updates
6.11 Erregierre SpA
6.11.1 Erregierre SpA Corporation Information
6.11.2 Erregierre SpA Mesalazine Description and Business Overview
6.11.3 Erregierre SpA Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Erregierre SpA Mesalazine Product Portfolio
6.11.5 Erregierre SpA Recent Developments/Updates
6.12 CTX Lifescience
6.12.1 CTX Lifescience Corporation Information
6.12.2 CTX Lifescience Mesalazine Description and Business Overview
6.12.3 CTX Lifescience Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 CTX Lifescience Mesalazine Product Portfolio
6.12.5 CTX Lifescience Recent Developments/Updates
6.13 Ishita Active Pharma Ingredients
6.13.1 Ishita Active Pharma Ingredients Corporation Information
6.13.2 Ishita Active Pharma Ingredients Mesalazine Description and Business Overview
6.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Ishita Active Pharma Ingredients Mesalazine Product Portfolio
6.13.5 Ishita Active Pharma Ingredients Recent Developments/Updates
6.14 YC Biotech (Jiangsu)
6.14.1 YC Biotech (Jiangsu) Corporation Information
6.14.2 YC Biotech (Jiangsu) Mesalazine Description and Business Overview
6.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.14.4 YC Biotech (Jiangsu) Mesalazine Product Portfolio
6.14.5 YC Biotech (Jiangsu) Recent Developments/Updates
6.15 Xinxiang Tianfeng Fine Chemical
6.15.1 Xinxiang Tianfeng Fine Chemical Corporation Information
6.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine Description and Business Overview
6.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine Product Portfolio
6.15.5 Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
7 Mesalazine Manufacturing Cost Analysis
7.1 Mesalazine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mesalazine
7.4 Mesalazine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mesalazine Distributors List
8.3 Mesalazine Customers
9 Mesalazine Market Dynamics
9.1 Mesalazine Industry Trends
9.2 Mesalazine Growth Drivers
9.3 Mesalazine Market Challenges
9.4 Mesalazine Market Restraints
10 Global Market Forecast
10.1 Mesalazine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mesalazine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Mesalazine by Type (2022-2027)
10.2 Mesalazine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mesalazine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Mesalazine by Application (2022-2027)
10.3 Mesalazine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mesalazine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Mesalazine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Mesalazine Sales (Ton) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Mesalazine Sales (Ton) Comparison by Application (2021-2027)
Table 3. Global Mesalazine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Mesalazine Covered in This Study
Table 5. Global Mesalazine Sales (Ton) of Key Manufacturers (2016-2021)
Table 6. Global Mesalazine Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Mesalazine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Mesalazine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Mesalazine Average Price (US$/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Mesalazine Manufacturing Sites and Area Served
Table 11. Manufacturers Mesalazine Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mesalazine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mesalazine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Mesalazine Sales by Region (2016-2021) & (Ton)
Table 16. Global Mesalazine Sales Market Share by Region (2016-2021)
Table 17. Global Mesalazine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Mesalazine Sales by Country (2016-2021) & (Ton)
Table 19. North America Mesalazine Sales Market Share by Country (2016-2021)
Table 20. North America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Mesalazine Revenue Market Share by Country (2016-2021)
Table 22. Europe Mesalazine Sales by Country (2016-2021) & (Ton)
Table 23. Europe Mesalazine Sales Market Share by Country (2016-2021)
Table 24. Europe Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Mesalazine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Mesalazine Sales by Region (2016-2021) & (Ton)
Table 27. Asia Pacific Mesalazine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Mesalazine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Mesalazine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Mesalazine Sales by Country (2016-2021) & (Ton)
Table 31. Latin America Mesalazine Sales Market Share by Country (2016-2021)
Table 32. Latin America Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Mesalazine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Mesalazine Sales by Country (2016-2021) & (Ton)
Table 35. Middle East and Africa Mesalazine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Mesalazine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Mesalazine Revenue Market Share by Country (2016-2021)
Table 38. Global Mesalazine Sales (Ton) by Type (2016-2021)
Table 39. Global Mesalazine Sales Market Share by Type (2016-2021)
Table 40. Global Mesalazine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Mesalazine Revenue Share by Type (2016-2021)
Table 42. Global Mesalazine Price (US$/Kg) by Type (2016-2021)
Table 43. Global Mesalazine Sales (Ton) by Application (2016-2021)
Table 44. Global Mesalazine Sales Market Share by Application (2016-2021)
Table 45. Global Mesalazine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Mesalazine Revenue Share by Application (2016-2021)
Table 47. Global Mesalazine Price (US$/Kg) by Application (2016-2021)
Table 48. PharmaZell Corporation Information
Table 49. PharmaZell Description and Business Overview
Table 50. PharmaZell Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 51. PharmaZell Mesalazine Product
Table 52. PharmaZell Recent Developments/Updates
Table 53. Syntese A/S Corporation Information
Table 54. Syntese A/S Description and Business Overview
Table 55. Syntese A/S Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 56. Syntese A/S Mesalazine Product
Table 57. Syntese A/S Recent Developments/Updates
Table 58. Cambrex Corporation Corporation Information
Table 59. Cambrex Corporation Description and Business Overview
Table 60. Cambrex Corporation Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 61. Cambrex Corporation Mesalazine Product
Table 62. Cambrex Corporation Recent Developments/Updates
Table 63. Divis Laboratories Corporation Information
Table 64. Divis Laboratories Description and Business Overview
Table 65. Divis Laboratories Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 66. Divis Laboratories Mesalazine Product
Table 67. Divis Laboratories Recent Developments/Updates
Table 68. Chemi SpA Corporation Information
Table 69. Chemi SpA Description and Business Overview
Table 70. Chemi SpA Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 71. Chemi SpA Mesalazine Product
Table 72. Chemi SpA Recent Developments/Updates
Table 73. Ipca Laboratories Corporation Information
Table 74. Ipca Laboratories Description and Business Overview
Table 75. Ipca Laboratories Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 76. Ipca Laboratories Mesalazine Product
Table 77. Ipca Laboratories Recent Developments/Updates
Table 78. Hangzhou Brother Corporation Information
Table 79. Hangzhou Brother Description and Business Overview
Table 80. Hangzhou Brother Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 81. Hangzhou Brother Mesalazine Product
Table 82. Hangzhou Brother Recent Developments/Updates
Table 83. Lianyungang Fengheng Biopharm Corporation Information
Table 84. Lianyungang Fengheng Biopharm Description and Business Overview
Table 85. Lianyungang Fengheng Biopharm Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 86. Lianyungang Fengheng Biopharm Mesalazine Product
Table 87. Lianyungang Fengheng Biopharm Recent Developments/Updates
Table 88. Lasa Loboratory Corporation Information
Table 89. Lasa Loboratory Description and Business Overview
Table 90. Lasa Loboratory Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 91. Lasa Loboratory Mesalazine Product
Table 92. Lasa Loboratory Recent Developments/Updates
Table 93. Corden Pharma Bergamo Corporation Information
Table 94. Corden Pharma Bergamo Description and Business Overview
Table 95. Corden Pharma Bergamo Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 96. Corden Pharma Bergamo Mesalazine Product
Table 97. Corden Pharma Bergamo Recent Developments/Updates
Table 98. Erregierre SpA Corporation Information
Table 99. Erregierre SpA Description and Business Overview
Table 100. Erregierre SpA Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 101. Erregierre SpA Mesalazine Product
Table 102. Erregierre SpA Recent Developments/Updates
Table 103. CTX Lifescience Corporation Information
Table 104. CTX Lifescience Description and Business Overview
Table 105. CTX Lifescience Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 106. CTX Lifescience Mesalazine Product
Table 107. CTX Lifescience Recent Developments/Updates
Table 108. Ishita Active Pharma Ingredients Corporation Information
Table 109. Ishita Active Pharma Ingredients Description and Business Overview
Table 110. Ishita Active Pharma Ingredients Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 111. Ishita Active Pharma Ingredients Mesalazine Product
Table 112. Ishita Active Pharma Ingredients Recent Developments/Updates
Table 113. YC Biotech (Jiangsu) Corporation Information
Table 114. YC Biotech (Jiangsu) Description and Business Overview
Table 115. YC Biotech (Jiangsu) Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 116. YC Biotech (Jiangsu) Mesalazine Product
Table 117. YC Biotech (Jiangsu) Recent Developments/Updates
Table 118. Xinxiang Tianfeng Fine Chemical Corporation Information
Table 119. Xinxiang Tianfeng Fine Chemical Description and Business Overview
Table 120. Xinxiang Tianfeng Fine Chemical Mesalazine Sales (Ton), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2016-2021)
Table 121. Xinxiang Tianfeng Fine Chemical Mesalazine Product
Table 122. Xinxiang Tianfeng Fine Chemical Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Mesalazine Distributors List
Table 126. Mesalazine Customers List
Table 127. Mesalazine Market Trends
Table 128. Mesalazine Growth Drivers
Table 129. Mesalazine Market Challenges
Table 130. Mesalazine Market Restraints
Table 131. Global Mesalazine Sales Forecast by Type (2022-2027) & (Ton)
Table 132. Global Mesalazine Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Mesalazine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Mesalazine Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Mesalazine Sales Forecast by Application (2022-2027) & (Ton)
Table 136. Global Mesalazine Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Mesalazine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Mesalazine Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Mesalazine Sales Forecast by Region (2022-2027) & (Ton)
Table 140. Global Mesalazine Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Mesalazine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Mesalazine Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mesalazine
Figure 2. Global Mesalazine Market Share by Type in 2020 & 2027
Figure 3. Purity ? 97 % Product Picture
Figure 4. Purity ? 98 % Product Picture
Figure 5. Purity ? 99 % Product Picture
Figure 6. Global Mesalazine Market Share by Application in 2020 & 2027
Figure 7. Tablets
Figure 8. Capsules
Figure 9. Pellet and Granule
Figure 10. Suppository
Figure 11. Enema
Figure 12. Others
Figure 13. Global Mesalazine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Mesalazine Market Size 2016-2027 (US$ Million)
Figure 15. Global Mesalazine Sales 2016-2027 (Ton)
Figure 16. Global Mesalazine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 17. Mesalazine Sales Share by Manufacturers in 2020
Figure 18. Global Mesalazine Revenue Share by Manufacturers in 2020
Figure 19. The Global 5 and 10 Largest Mesalazine Players: Market Share by Revenue in 2020
Figure 20. Mesalazine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 21. Global Mesalazine Sales Market Share by Region (2016-2021)
Figure 22. Global Mesalazine Sales Market Share by Region in 2020
Figure 23. Global Mesalazine Revenue Market Share by Region (2016-2021)
Figure 24. Global Mesalazine Revenue Market Share by Region in 2020
Figure 25. U.S. Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Canada Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Germany Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. France Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. U.K. Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Italy Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Russia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. China Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Japan Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. South Korea Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. India Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Australia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Taiwan Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Indonesia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Thailand Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Malaysia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Philippines Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Vietnam Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Mexico Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Brazil Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Argentina Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Mesalazine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Mesalazine by Type (2016-2021)
Figure 50. Sales Market Share of Mesalazine by Application (2016-2021)
Figure 51. Sales Market Share of Mesalazine by Application in 2020
Figure 52. Revenue Share of Mesalazine by Application (2016-2021)
Figure 53. Revenue Share of Mesalazine by Application in 2020
Figure 54. Manufacturing Cost Structure of Mesalazine
Figure 55. Manufacturing Process Analysis of Mesalazine
Figure 56. Mesalazine Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
  • Global Methylprednisolone Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress The immune system. It is prescribed for a wide range of medical conditions, including autoimmune disorders and inflammatory diseases. The global Methylprednisolone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. Methylprednisolone is a widely used medication, and The market trend invol......
  • Global Ibuprofen Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84
    Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. The global Ibuprofen market was valued at US$ 93 million in 2023 and is anticipated to reach US$ 112.3 million by 2030, witnessing a CAGR of 2.7% during The forecast period 2024-2030. Market competition is intense. Xinhua Pharmaceutical, IOLCP,......
  • Global Mesalazine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132
    According to our LPI (LP Information) latest study, the global Mesalazine market size was valued at US$ 158.3 million in 2023. With growing demand in downstream market, the Mesalazine is forecast to a readjusted size of US$ 206 million by 2030 with a CAGR of 3.8% during review period. The research report highlights the growth potential of the global Mesalazine market. Mesalazine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and......
  • Global Drugs For Sinusitis Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Drugs For Sinusitis market size was valued at US$ 2187.4 million in 2023. With growing demand in downstream market, the Drugs For Sinusitis is forecast to a readjusted size of US$ 2827.4 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Drugs For Sinusitis market. Drugs For Sinusitis are expected to show stable growth in the future market. However, prod......
  • Global Celecoxib Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Celecoxib market size was valued at US$ 1243.6 million in 2023. With growing demand in downstream market, the Celecoxib is forecast to a readjusted size of US$ 2232 million by 2030 with a CAGR of 8.7% during review period. The research report highlights the growth potential of the global Celecoxib market. Celecoxib are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Ibuprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Ibuprofen market size was valued at US$ 91 million in 2023. With growing demand in downstream market, the Ibuprofen is forecast to a readjusted size of US$ 110.4 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Ibuprofen market. Ibuprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supp......
  • Global Ketoprofen Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Ketoprofen market size was valued at US$ 34 million in 2023. With growing demand in downstream market, the Ketoprofen is forecast to a readjusted size of US$ 39 million by 2030 with a CAGR of 2.0% during review period. The research report highlights the growth potential of the global Ketoprofen market. Ketoprofen are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Drugs for Sinusitis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Drugs for Sinusitis market: According to our latest research, the global Drugs for Sinusitis market looks promising in the next 5 years. As of 2022, the global Drugs for Sinusitis market was estimated at USD 2147.6 million, and it's anticipated to reach USD 3206.59 million in 2028, with a CAGR of 6.91% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dru......
  • Global Ibuprofen Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Ibuprofen market size was valued at USD 96 million in 2023 and is forecast to a readjusted size of USD 114.4 million by 2030 with a CAGR of 2.6% during review period. Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation. Market competitio......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs